These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29171337)

  • 21. Motor and cognitive assessment of infants and young boys with Duchenne Muscular Dystrophy: results from the Muscular Dystrophy Association DMD Clinical Research Network.
    Connolly AM; Florence JM; Cradock MM; Malkus EC; Schierbecker JR; Siener CA; Wulf CO; Anand P; Golumbek PT; Zaidman CM; Philip Miller J; Lowes LP; Alfano LN; Viollet-Callendret L; Flanigan KM; Mendell JR; McDonald CM; Goude E; Johnson L; Nicorici A; Karachunski PI; Day JW; Dalton JC; Farber JM; Buser KK; Darras BT; Kang PB; Riley SO; Shriber E; Parad R; Bushby K; Eagle M;
    Neuromuscul Disord; 2013 Jul; 23(7):529-39. PubMed ID: 23726376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Walking activity in a large cohort of boys with Duchenne muscular dystrophy.
    Lott DJ; Taivassalo T; Senesac CR; Willcocks RJ; Harrington AM; Zilke K; Cunkle H; Powers C; Finanger EL; Rooney WD; Tennekoon GI; Vandenborne K
    Muscle Nerve; 2021 Feb; 63(2):192-198. PubMed ID: 33188573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
    Manzur AY; Kuntzer T; Pike M; Swan A
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003725. PubMed ID: 18254031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Longitudinal Study of Quantitative Muscle Strength and Functional Motor Ability in Ambulatory Boys with Duchenne Muscular Dystrophy.
    Buckon CE; Sienko SE; Fowler EG; Bagley AM; Staudt LA; Sison-Williamson M; Heberer KR; McDonald CM; Sussman MD
    J Neuromuscul Dis; 2022; 9(2):321-334. PubMed ID: 34924398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy.
    Nagy S; Schmidt S; Hafner P; Klein A; Rubino-Nacht D; Gocheva V; Bieri O; Vuillerot C; Bonati U; Fischer D
    J Vis Exp; 2019 Jan; (143):. PubMed ID: 30688316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reliability of the walking energy cost test and the six-minute walk test in boys with Duchenne muscular dystrophy.
    Kempen JC; Harlaar J; van der Kooi AJ; de Groot IJ; van den Bergen JC; Niks EH; Verschuuren JJ; Brehm MA
    Neuromuscul Disord; 2014 Mar; 24(3):216-21. PubMed ID: 24365209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone health measures in glucocorticoid-treated ambulatory boys with Duchenne muscular dystrophy.
    Tian C; Wong BL; Hornung L; Khoury JC; Miller L; Bange J; Rybalsky I; Rutter MM
    Neuromuscul Disord; 2016 Nov; 26(11):760-767. PubMed ID: 27614576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-related longitudinal changes in metabolic energy expenditure during walking in boys with Duchenne muscular dystrophy.
    Brehm MA; Kempen JC; van der Kooi AJ; de Groot IJ; van den Bergen JC; Verschuuren JJ; Niks EH; Harlaar J
    PLoS One; 2014; 9(12):e115200. PubMed ID: 25506914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 6-minute walk test in Duchenne/Becker muscular dystrophy: longitudinal observations.
    McDonald CM; Henricson EK; Han JJ; Abresch RT; Nicorici A; Atkinson L; Elfring GL; Reha A; Miller LL
    Muscle Nerve; 2010 Dec; 42(6):966-74. PubMed ID: 21038378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal changes in energy cost during walking in boys with Duchenne Muscular Dystrophy (DMD).
    Sienko S; Buckon CE; Bagley A; Staudt L; Fowler E; Heberer K; Sison-Williamson M; McDonald C; Sussman MD
    Gait Posture; 2021 Oct; 90():301-306. PubMed ID: 34564002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early signs of gait deviation in Duchenne muscular dystrophy.
    Doglio L; Pavan E; Pernigotti I; Petralia P; Frigo C; Minetti C
    Eur J Phys Rehabil Med; 2011 Dec; 47(4):587-94. PubMed ID: 21912365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physical Activity in Boys With Duchenne Muscular Dystrophy Is Lower and Less Demanding Compared to Healthy Boys.
    Heutinck L; Kampen NV; Jansen M; Groot IJ
    J Child Neurol; 2017 Apr; 32(5):450-457. PubMed ID: 28112012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early developmental milestones in Duchenne muscular dystrophy.
    van Dommelen P; van Dijk O; de Wilde JA; Verkerk PH
    Dev Med Child Neurol; 2020 Oct; 62(10):1198-1204. PubMed ID: 32692451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strong correlation between the 6-minute walk test and accelerometry functional outcomes in boys with Duchenne muscular dystrophy.
    Davidson ZE; Ryan MM; Kornberg AJ; Walker KZ; Truby H
    J Child Neurol; 2015 Mar; 30(3):357-63. PubMed ID: 24762862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative Skeletal Muscle MRI: Part 1, Derived T2 Fat Map in Differentiation Between Boys With Duchenne Muscular Dystrophy and Healthy Boys.
    Johnston JH; Kim HK; Merrow AC; Laor T; Serai S; Horn PS; Kim DH; Wong BL
    AJR Am J Roentgenol; 2015 Aug; 205(2):W207-15. PubMed ID: 26204309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors for changes in the timed 4-stair climb in patients with Duchenne muscular dystrophy, and implications for measuring drug efficacy: A multi-institutional collaboration.
    Goemans N; Wong B; Van den Hauwe M; Signorovitch J; Sajeev G; Cox D; Landry J; Jenkins M; Dieye I; Yao Z; Hossain I; Ward SJ;
    PLoS One; 2020; 15(6):e0232870. PubMed ID: 32555695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prednisolone therapy in Duchenne muscular dystrophy prolongs ambulation and prevents scoliosis.
    Yilmaz O; Karaduman A; Topaloğlu H
    Eur J Neurol; 2004 Aug; 11(8):541-4. PubMed ID: 15272899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Walking and weakness in children: a narrative review of gait and functional ambulation in paediatric neuromuscular disease.
    Kennedy RA; Carroll K; McGinley JL; Paterson KL
    J Foot Ankle Res; 2020 Mar; 13(1):10. PubMed ID: 32122377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade.
    Biggar WD; Harris VA; Eliasoph L; Alman B
    Neuromuscul Disord; 2006 Apr; 16(4):249-55. PubMed ID: 16545568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gait pattern in Duchenne muscular dystrophy.
    D'Angelo MG; Berti M; Piccinini L; Romei M; Guglieri M; Bonato S; Degrate A; Turconi AC; Bresolin N
    Gait Posture; 2009 Jan; 29(1):36-41. PubMed ID: 18656361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.